Last reviewed · How we verify

NCT03666299: LIPPS

Lidocaine Infusion for Postthoracotomy Pain Syndrome

Status unknown NA Last updated 7 November 2018
What this trial tests

NA trial testing Lidocaine in Thoracic Surgery, Video-Assisted in 72 participants. Status unknown.

Timeline
6 November 2018
Primary endpoint
30 June 2019
30 June 2019

Quick facts

Lead sponsorGuangzhou First People's Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment72
Start date6 November 2018
Primary completion30 June 2019
Estimated completion30 June 2019
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Guangzhou First People's Hospital

Who can join

Adults 18 to 70, any sex, with Thoracic Surgery, Video-Assisted or Lidocaine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to investigate lidocaine infusion to reduce postthoractomy pain syndrome after thoracic Surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lidocaine

Trials testing the same drug.

Other Guangzhou First People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03666299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing